Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-07-31
1989-01-10
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
548336, 548339, 514300, 514326, 514183, 514215, 514397, 514398, 514302, 546113, 546210, 546115, 540476, 540480, 540521, 540524, C07D40112, C07D23391, A61K 31415, A61K 31445
Patent
active
047973978
ABSTRACT:
Certain .alpha.-[(2-nitro-1H-imidazol-1-yl)methyl]-aziridinylethanols and the corresponding aziridine-ring opened analogs are useful as radiation sensitizers for X-irradiation therapy of tumors.
REFERENCES:
patent: 4241060 (1980-12-01), Smithen
patent: 4282232 (1981-08-01), Agrawal
patent: 4581368 (1986-04-01), Ahmed et al.
patent: 4596817 (1986-06-01), Ahmed et al.
patent: 4631289 (1986-12-01), Ahmed et al.
G. E. Adams et al., Chemotherapy, vol. 7, pp. 187-206, Plenum Press, New York, 1976.
Suto Mark J.
Werbel Leslie M.
Daignault Ronald A.
Ford John M.
Warner-Lambert & Company
LandOfFree
2-nitroimidazole derivatives useful as radiosensitizers for hypo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-nitroimidazole derivatives useful as radiosensitizers for hypo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-nitroimidazole derivatives useful as radiosensitizers for hypo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107927